Eurofins Diatherix

What Eurofins Diatherix does

Eurofins Diatherix Laboratories, LLC is a CLIA-certified and CAP-accredited clinical laboratory headquartered at 601 Genome Way, Suite 2100, Huntsville, Alabama, on the Hudson Alpha Institute for Biotechnology campus. Founded in 2008 as an independent molecular diagnostics company and subsequently acquired by Eurofins Scientific SE, the company operates as a wholly-owned subsidiary within the Eurofins Clinical Diagnostics division, alongside Boston Heart Diagnostics, Viracor, empowerDX, Eurofins Genomics, and Eurofins Transplant Genomics.

The company's core technology is TEM-PCR™ (Target Enriched Multiplex Polymerase Chain Reaction), a proprietary multiplex amplification platform that enriches target DNA before amplification, reducing background noise and improving sensitivity and specificity versus conventional multiplex PCR. Eurofins Diatherix uses this platform to deliver a test menu organized into five infectious-disease categories: respiratory infection (30 tests), gastrointestinal infection (7 tests), genital health/STI (9 tests), urinary tract infection, and wound/skin/soft tissue infection (11 tests). Supplementary offerings include SARS-CoV-2 PCR, a multiplex "Flu Plus" panel (SARS-CoV-2, Influenza A/B, RSV A&B, rhinovirus/enterovirus), a COVID-19 Panel adding five bacterial targets, Elisa Testing for fecal biomarkers, and traditional urine culture with sensitivity testing. Standard turnaround is one day, materially faster than the 48–72 hour norm for conventional culture.

Revenue is generated primarily on a fee-for-service basis for diagnostic tests billed to healthcare providers, insurance carriers, and self-pay patients (SARS-CoV-2 self-pay priced at $75 effective January 1, 2021). Specimen logistics are managed through FedEx Clinical Paks (UN3373) with Priority Overnight option, and providers order tests and retrieve results through a WebClient Portal supported by a phone- and email-based Client Services team. The company has served over 68,431 physicians since 2009 and processes approximately 4 million PCR tests per year across the United States.

Name

Eurofins Diatherix

Legal name

Eurofins Diatherix Laboratories, LLC

Website

https://eurofins-diatherix.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

101–250 employees

Short description

Eurofins Diatherix is a CLIA-certified and CAP-accredited clinical laboratory in Huntsville, Alabama, providing proprietary TEM-PCR molecular diagnostic testing for infectious diseases to U.S. hospitals and physician practices, operating as a subsidiary of Eurofins Scientific SE.

Ownership category

akta.pro rank

Headquarters

HQ city

Huntsville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Molecular Diagnostic Testing Services: Clinical laboratory testing services for infectious diseases including respiratory, gastrointestinal, genital health, urinary tract, and wound/skin infections. Revenue generated through billable diagnostic tests to healthcare providers, insurance carriers, and patients directly. Offers client billing and patient self-pay options. SARS-CoV-2 testing available at $75 self-pay.
2. Specimen Collection and Supply Sales: Provides specimen collection supplies (transport tubes, FedEx Clinical Paks, labels) to client healthcare facilities. Supplies shipped via FedEx Ground with optional Priority Overnight delivery.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Eurofins Diatherix is a CLIA and CAP-accredited clinical laboratory providing molecular diagnostic testing services for infectious diseases to hospitals and physicians. The lab uses its proprietary TEM-PCR multiplex amplification technology to deliver one-day results across respiratory, gastrointestinal, genital health, urinary tract, and wound/skin/soft tissue infections. Complementing TEM-PCR, the lab also offers Elisa fecal biomarker testing and traditional urine culture and sensitivity testing.

Product overview

Eurofins Diatherix is a CLIA and CAP-accredited clinical laboratory offering molecular diagnostic testing services for infectious diseases. The core technology is proprietary TEM-PCR™ (Target Enriched Multiplex PCR), a multiplex amplification platform that enriches target DNA before amplification to achieve high sensitivity and specificity. The company operates as a single integrated laboratory with multiple testing service categories: Respiratory Testing (30 tests), Gastrointestinal Testing (7 tests), Genital Health Testing (9 tests), Urinary Tract Infection Testing, and Wound/Skin & Soft Tissue Testing (11 tests). Additional offerings include specific COVID-19 related tests (SARS-CoV-2 single-target, Flu Plus, and COVID-19 Panel), Elisa Testing for fecal biomarkers, and Urine Culture and Sensitivity testing. Clients access services through a WebClient Portal for ordering and results retrieval. The laboratory delivers one-day results to support timely clinical decision-making.

Differentiator

Problem solved

Functional benefit

Products and services

• TEM-PCR (Target Enriched Multiplex Polymerase Chain Reaction)
• Respiratory Testing
• Gastrointestinal Testing
• Genital Health Testing
• Urinary Tract Infection Testing
• Wound/Skin & Soft Tissue Testing
• SARS-CoV-2 PCR Test
• Flu Plus Test
• COVID-19 Panel Test
• Elisa Testing
• Urine Culture and Sensitivity Testing
• WebClient Portal

Quantifiable outcome

• 68,431+ physicians served since 2009 with millions of tests nationwide
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Hudson Alpha Institute for BiotechnologycoreStrategic or Co-development PartnerEurofins Diatherix is located within the Hudson Alpha Institute for Biotechnology campus in Huntsville, Alabama. This placement within a biotechnology research park supports the company's focus on molecular diagnostics and innovation in infectious disease testing.
• Eurofins Clinical DiagnosticscoreStrategic or Co-development PartnerEurofins Diatherix joined forces with Eurofins to form the current company. As part of the Eurofins Clinical Diagnostics division, the company benefits from shared resources, research capabilities, and access to Eurofins' broader diagnostic network including Boston Heart Diagnostics, Viracor, EmpowerDX, and other specialized labs.
• Vanderbilt University Medical CenterminorStrategic or Co-development PartnerCollaborative research study on Performance of TEM-PCR vs Culture for Bacterial Identification in Pediatric Musculoskeletal Infections published through Vanderbilt University Medical Center.

Scale indicators5 records

Expansion highlights5 records

Emerging players

• Accelerate Diagnostics: Accelerate Diagnostics focuses on rapid identification and antibiotic susceptibility testing for bloodstream and other serious infections, partially overlapping with Eurofins Diatherix's antimicrobial-resistance-focused molecular offerings.

Direct peers

• Hologic (Panther Fusion): Hologic's Panther Fusion system provides fully automated, random-access molecular testing for respiratory, STI, and other infectious disease targets. It competes with TEM-PCR-based send-out testing by enabling hospital labs to run multiplex PCR in-house.
• BioFire Diagnostics (bioMérieux): BioFire's FilmArray syndromic panels (respiratory, GI, bloodstream, meningitis/encephalitis) are the leading on-premise multiplex PCR systems used in hospitals for infectious disease detection — directly competing with Eurofins Diatherix's TEM-PCR send-out panels in the same clinical use cases.
• Viracor Eurofins: Viracor Eurofins is a sister specialty reference lab within the same Eurofins Clinical Diagnostics division, offering molecular and immunology testing for transplant, infectious disease, and immunology — overlapping directly with Eurofins Diatherix on hospital-based infectious disease send-outs.
• Cepheid (Danaher): Cepheid's GeneXpert system delivers rapid, on-demand molecular PCR testing for infectious diseases (MTB, MRSA, C. difficile, respiratory viruses, STI). It competes head-to-head with Eurofins Diatherix for hospital molecular diagnostics volume, especially in decentralised settings.

Broad incumbents

• Quest Diagnostics: Quest is one of the two largest U.S. reference laboratories and offers a broad molecular infectious disease menu plus its own proprietary PCR assays. It competes with Eurofins Diatherix on hospital send-outs while also serving physician offices and direct-to-consumer testing.
• Mayo Clinic Laboratories: Mayo Clinic Laboratories is a major esoteric reference lab offering extensive molecular infectious disease and specialty testing panels, competing with Eurofins Diatherix for hospital and health system send-out volume where deep test menus are required.
• ARUP Laboratories: ARUP is a leading U.S. academic-affiliated reference lab offering an extensive esoteric and molecular infectious disease menu. It is a comparable specialty reference lab competing for hospital and health system send-out contracts in similar infectious disease categories.
• Laboratory Corporation of America (Labcorp): Labcorp is a national full-service reference lab offering PCR-based infectious disease, STI, and respiratory pathogen testing with a national logistics network. Its scale and breadth compete with Eurofins Diatherix's specialty send-out business for both hospital and physician office customers.
• Roche Diagnostics (cobas): Roche's cobas systems and assays cover a broad molecular infectious disease menu (viral load, STI, respiratory) used in both hospital labs and reference lab settings, providing integrated competition across Eurofins Diatherix's customer segments.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/diatherix
• Facebookfacebook.com/Diatherix-Eurofins-Clinical-Diagnostics-107300133966819

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurofins Diatherix